Skip to main content

ICH Q5B Analysis of the expression construct in cell lines used for production of r-DNA derived protein products (CPMP/ICH/139/95)

1. Purpose of ICH Q5B:

ICH Q5B was developed to provide a systematic approach for the analysis of the expression construct in cell lines used in the manufacturing of biopharmaceutical products. This guideline ensures that the expression system and the genetic material encoding the target protein are well-characterized, stable, and consistent throughout the production process.

2. Expression Construct Characterization:

The guideline emphasizes the importance of thoroughly characterizing the expression construct, which includes the DNA sequence encoding the target protein and all associated regulatory elements. This includes promoters, enhancers, terminators, and any other genetic components necessary for gene expression.

Detailed documentation of the construct, including sequence data, maps, and structural information, is essential to confirm its identity and integrity.

3. Sequence Analysis:

Sequence analysis is a critical component of expression construct characterization. The guideline suggests conducting a comprehensive analysis of the nucleotide sequence to ensure it matches the intended sequence and to identify any mutations or variations that might affect product quality or safety.

4. Stability Assessment:

The stability of the expression construct is a key consideration. It is important to demonstrate that the construct remains stable throughout the cell line development process and during large-scale production. Any genetic changes or instability in the construct could lead to variations in product quality.

Stability studies may involve monitoring the construct over multiple cell passages and production batches to assess its consistency.

5. Comparability Studies:

If modifications or changes are made to the expression construct during development or manufacturing, comparability studies may be required. These studies aim to demonstrate that the modified construct does not adversely affect the quality, safety, or efficacy of the final product when compared to the original construct.

6. Regulatory Compliance:

Compliance with ICH Q5B guidelines is typically required by regulatory authorities when submitting applications for marketing authorization. Companies developing r-DNA derived protein products must adhere to these guidelines to ensure the quality and safety of their products.

7. Impact on Product Quality:

The analysis of the expression construct is just one aspect of ensuring product quality. It is interconnected with other critical factors, including cell line development, fermentation processes, purification methods, and analytical assays, all of which contribute to the final product's quality and consistency.

8. Documentation:

Comprehensive documentation of all aspects related to the expression construct, including sequence information, characterization data, and stability studies, should be maintained and provided to regulatory authorities as part of the submission process.

In summary, ICH Q5B outlines a rigorous process for the analysis and characterization of expression constructs used in the production of r-DNA derived protein products. This process ensures that the genetic material and associated regulatory elements are well-understood, stable, and consistent, ultimately contributing to the quality and safety of biopharmaceutical products. Compliance with these guidelines is crucial for obtaining regulatory approval and maintaining product integrity throughout its lifecycle.

Reference:

https://database.ich.org/sites/default/files/Q5B%20Guideline.pdf

Labels:

Popular posts from this blog

Ago2 Immunoprecipitation for RISC-siRNA Quantitation

 Ago2 (Argonaute 2) immunoprecipitation (IP) is a technique used to isolate RNA-induced silencing complexes (RISC) from cell lysates. This method allows for the specific enrichment of active RISC complexes bound to small interfering RNA (siRNA) or microRNA (miRNA) within cells. By isolating these complexes, researchers can then quantify the siRNA associated with Ago2, which is an essential step in determining the efficacy of RISC loading and siRNA activity. Here’s a detailed overview of how Ago2 immunoprecipitation is performed for RISC-siRNA quantitation: Steps in Ago2 Immunoprecipitation for RISC-siRNA Quantitation Cell Lysis and Preparation of Lysate : Sample Preparation : Collect cells that have been treated with siRNA, then wash them with cold phosphate-buffered saline (PBS) to remove extracellular contaminants. Lysis : Lyse the cells in a gentle, RNA-preserving lysis buffer that typically includes detergents (e.g., NP-40 or Triton X-100), protease inhibitors, and RNase inhibi...
Read more

Guideline on development and manufacture of lentiviral vectors (CHMP/BWP/2458/03)

The guideline with the reference number "CHMP/BWP/2458/03" pertains to the "Guideline on Development and Manufacture of Lentiviral Vectors." This guideline was developed by the Committee for Medicinal Products for Human Use (CHMP) and the Biotechnology Working Party (BWP) of the European Medicines Agency (EMA). It provides recommendations and regulatory guidance for the development and manufacture of lentiviral vectors, which are widely used in gene therapy and cell therapy applications. Here's an overview of the key points covered in this guideline: 1. Introduction: The guideline begins with an introduction highlighting the increasing importance of lentiviral vectors in advanced therapies and the need for guidance on their development and manufacture. 2. Scope: It defines the scope of the guideline, which covers the development and manufacture of lentiviral vectors intended for use in gene therapy and cell therapy products for human use. 3. Quality and Characte...
Read more

Stem-Loop PCR for siRNA

 Stem-loop PCR is a method often used for detecting and quantifying small RNAs, such as siRNA or miRNA, which are typically difficult to amplify directly due to their short lengths. The method involves the design of a stem-loop reverse transcription (RT) primer, which enhances specificity and stability of the short RNA during the RT-PCR process, allowing for sensitive detection and quantification of the siRNA. Here’s a detailed guide to how stem-loop PCR can be applied to siRNA detection: Key Steps in Stem-Loop PCR for siRNA Designing the Stem-Loop RT Primer : Structure : The stem-loop RT primer consists of a loop region flanked by complementary sequences on either side (the "stem"), which will fold back on itself to form a hairpin structure. Specific Binding Region : A short sequence complementary to the 3’ end of the siRNA is added at the end of the stem-loop primer to ensure specific binding to the siRNA target. Stabilization : The loop structure helps prevent primer-dimer...
Read more

FDA Guidance on Studying Multiple Versions of Cellular or Gene Therapy Products in Early-Phase Clinical Trials

 The purpose of this guidance is to offer advice to sponsors interested in conducting early-phase clinical trials for a single disease involving multiple variations of a cellular or gene therapy product. Sponsors aim to gather preliminary safety and efficacy data for these product variations within a single clinical trial. It's important to note that even though multiple product versions are studied together, each version is distinct and typically requires a separate investigational new drug application (IND) submission to the FDA. The primary goal of these early-phase clinical studies is to inform decisions about which product version(s) should be advanced for further development in later-phase trials. As such, these studies are not designed to provide the main evidence of effectiveness needed for a marketing application. They are generally not statistically powered to demonstrate a significant difference in efficacy between the different study arms. In this guidance, the FDA prov...
Read more

Stem loop RT-PCR for Detection of siRNA in Animal Tissues

Step Loop RT-PCR for Detection of Small Interfering RNA (siRNA) The recent publications described a novel used the novel method for the detection of siRNAs using a TaqMan®-based approach. This approach utilizes similar strategy that has been used for microRNA detection. The approach is illustrated in below.  In brief, the RT step occurs in the presence of a stem-loop RT primer that is complementary to the last 6–10 bases of the 3′ end of the antisense strand of the target siRNA. The stem-loop primer contains an additional universal sequence at the 5′ end that facilitates a TaqMan-based detection strategy in the subsequent qPCR step. As in the case of microRNA, the forward primer for qPCR is sequence-specific for the target siRNA. For sequence compositions that yield a low predicted melting temperature (Tm), the forward primer is designed as a tailed primer to help increase Tm. Stem Loop PCR for SiRNA Detection Step 1: Preparation of liver and plasma samples for the quanti...
Read more